Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-279-1 | CAS number: 118-82-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study according to recent guieline and under GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- AN-2
- IUPAC Name:
- AN-2
- Reference substance name:
- 4,4'-methylene bis(2,6-di-tert-butylphenol)
- IUPAC Name:
- 4,4'-methylene bis(2,6-di-tert-butylphenol)
- Reference substance name:
- 2,2',6,6'-tetra-tert-butyl-4,4'-methylenediphenol
- EC Number:
- 204-279-1
- EC Name:
- 2,2',6,6'-tetra-tert-butyl-4,4'-methylenediphenol
- Cas Number:
- 118-82-1
- Molecular formula:
- C29H44O2
- IUPAC Name:
- 2,6-di-tert-butyl-4-[(3,5-di-tert-butyl-4-hydroxyphenyl)methyl]phenol
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): AN-2
- Analytical purity: 99/45%
Constituent 1
Constituent 2
Constituent 3
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Additional strain / cell type characteristics:
- other: K-1 cell line
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S9 mix from male rats
- Test concentrations with justification for top dose:
- Experiment 1 with and without S9 mix:
0 (DMSO solvent), 200, 100, 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78, 0.39, 0.2, 0.1 micro-g/ml
Experiment 2 with S9 mix:
0 (DMSO solvent), 300, 200, 150, 100, 75, 50, 30, 10, 5 micro-g/ml
Experiment 2 without S9 mix:
0 (DMSO solvent), 300, 200, 150, 100, 75, 50, 30, 10, 5, 2.5, 1.25 micro-g/ml - Vehicle / solvent:
- Dimethyl sulfoxide (DMSO)
- Justification for choice of solvent/vehicle: based on a solubility test wih solvents suitable for the test system. The test substance coudl be dissolved up to 5mg/ml in DMSO after sonification for 15 min at 40 deg. C
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Remarks:
- cyclophosphamide in the presence of S9, mitomycin c in the absence of S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in tissue culture flasks with culture medium
DURATION
- Exposure duration:
Experiment 1 with and without S9: 4 h
Experiment 2:
with S9: 4 h
without S9: 18 h
- Expression time (cells in growth medium): 18 h
- Fixation time (start of exposure up to fixation or harvest of cells): 16 h (2 h before the end of the total incubation period)
SPINDLE INHIBITOR (cytogenetic assays): Colcemid (0.1 micro-g/ml)
NUMBER OF REPLICATIONS: 2 independent experiments, 2 cultures per concentration
NUMBER OF CELLS EVALUATED: 100 metaphases per culturr, 200 per concentration
Three concentrations of the test substance were selected for the evaluation based on the cytotoxicity (highest should reduce mitotiic index at least 50% but not more than 70%).
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index - Evaluation criteria:
- Positive response criteria: concentration relaed increase or reproducible increase in number of cells with structural chromosomal aberrations.
Equivocal response: percentage of cells with structural chromosomal aberrations is statistically significantly higher than that of the negative controls (0.05
A test substance is considered clasogenic if a concentration related increase of the percentage of cells with structural chromosomal aberrations over the concurrent control frequency is observed, or if a single positive test point is observed in both tests at approximately the same dose level.
A test substance is considered negative if it produces neither a dose rleated increase in the numberstructural chromosomal aberrations, nor a reproducible positive response at any of the test points.
Both statistical significance and biologicall relevance are consideed together in the evaluation. - Statistics:
- Fisher's exact probability test (two-sided)
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: at 300 and 200 micro-l/ml precipitation of the TS occurred in cultures with and without S9 mix. Turbidity of the medium was observed down to concentrations of 50 micro-g/ml
Test concentrations selected for CA scoring:
Exp. 1 with S9 mix:
DMSO control, cyclophosphamide control 5 micro-g/ml, TS: 200, 100, 50 micro-l/ml
without S 9 mix:
DMSO control, mitomycin c control 0.1 micro-g/ml, TS: 200, 100, 50 micro-l/ml
Experiment 2:
with S9 mix:
DMSO control, cyclophosphamide control 5 micro-g/m, TS: 300, 200, 100 micro-l/ml
without S 9 mix:
DMSO control, mitomycin c control 0.1 micro-g/ml, TS: 10, 5, 2.5 micro-l/ml
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Experiment 1 with S9 mitotic index reduced: 71% of controls at 200 micro-g/ml, without S9: 54% at 200 and 59 at 100 micro-g/ml
Experiment 2: with S9 mitotic index reduced: 40% of controls at 300 micro-g/ml, 49% ot 200 micro-g/ml, 80% at 100 micro-g/ml, without S9: 47% at 10 and87% at 5 micro-g/ml, 91% at 2.5 micro-g/ml.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with and without metabolic activation
Under the conditions of this study the test substance was not clastogenic to Chinese Hamster Ovary cells - Executive summary:
The test substance AN-2 was examined for its potential to induce structural chromosomal aberrations in Chinese Hamster Ovary (CHO) cells, in both the absence and presence of a metabolic activation system (S9-mix). Dimethylsulfoxide (DMSO) was used as vehicle for the test substance. Two chromosomal aberration tests were conducted. In all instances, duplicate cultures were used. Dose levels, ranging from 1.25 to 300 micro-g/ml, were tested. Both solubility and cytotoxicity were used for dose level selection. Mitotic index reduction was used as indication for cell toxicity.
In the first chromosomal aberration test, in both the absence and presence of a metabolic activation system (S9-mix). treatment/harvesting time was 4/18 hours (pulse treatment) and three concentrations of the test substance (50, 100 and 200 micro-g/ml) were selected for chromosomal aberration analysis. In the pulse treatment group with metabolic activation (S9-mix), the highest concentration was weakly cytotoxic to the cells. In the pulse treatment group without metabolic activation (S9- mix), the two highest concentrations were clearly cytotoxic to the cells.
In the second chromosomal aberration test, in the presence of S9-mix. treatment/harvesting time was 4/18 hours (pulse treatment) and three concentrations of the test substance (100, 200 and 300 micro-g/ml) were selected for chromosomal aberration analysis. Dose-related cytotoxicity was induced by the test substance. In the absence of S9-mix, treatment/harvest time was 18/18 hours (continuous treatment) and three concentrations of the test substance (2.5, 5 and 10 micro-g/ml) were selected for chromosomal aberration analysis. The test substance was weakly cytotoxic to the cells at the two lowest concentrations and clearly cytotoxic to the cells at the highest concentration. At the next higher concentration (30 micro-g/ml), the test substance was too cytotoxic and therefore not selected for chromosomal aberration analysis.
In both the first and second chromosomal aberration lest, the test substance AN-2 did not induce a statistically significant increase in the number of aberrant cells, at any of the concentrations and treatment periods analysed. when compared to the number of aberrant cells found in the vehicle (DMSO) control cultures. In both chromosomal aberration tests, the numbers of aberrant cells. found in the vehicle (DMSO) control cultures. were within the historical range and the positive control substances mitomycin C (in the absence of the S9·mix) and cyclophosphamide (in the presence of the S9-mix) induced the expected statistically significant increases in the incidence of structural chromosomal aberrations. This demonstrates the validity of the assay. Under the conditions used in this study. the test substance AN-2 was not clastogenic to Chinese Hamster Ovary (CHO) cells.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
За да гарантираме, че се възползвате максимално от функциите на нашия уебсайт, сме въвели „бисквитки“.